Clinical Trials Logo

Clinical Trial Summary

A multicenter prospective registry planned to recruit more than 5 000 patients with renal artery stenosis was carried out in China. This primary purpose of this study was to evaluate the safety and efficacy of renal artery revascularization in the real world. The secondary purpose was to investigate the etiologic distribution of renal artery stenosis and optimize the indications for renal artery revascularization.


Clinical Trial Description

Currently,the endovascular therapy of renal artery stenosis (especially atherosclerotic) remains in dispute. Some randomized control trials published in recent years (including ASTRAL and CORAL trials) showed the lack of additional benefit for renal artery revascularization compared with sole medical therapy. However,these randomized control trials presented a number of limitations including low numbers of patients and non-stringent inclusion criteria. Given clinical medical practice entering the era of big data, the large-sample real-word studies would be more objective to answer some pending issues of randomized controlled trial.Therefore,a multicenter prospective registry planned to recruit more than 5 000 patients with renal artery stenosis was carried out. This primary purpose of this study was to evaluate the safety and efficacy of renal artery revascularization in the real world. The secondary purpose was to investigate the etiologic distribution of renal artery stenosis and optimize the indications for renal artery revascularization. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03080519
Study type Interventional
Source Chinese Academy of Medical Sciences, Fuwai Hospital
Contact Xiongjing Jiang, MD
Phone 86-1088322385
Email jxj103@hotmail.com
Status Not yet recruiting
Phase N/A
Start date April 2017
Completion date April 2024

See also
  Status Clinical Trial Phase
Completed NCT01344460 - Gadobutrol Enhanced MRA of the Renal Arteries Phase 3
Recruiting NCT00868972 - Renal Stenting With Distal Atheroembolic Protection Phase 2/Phase 3
Completed NCT00150943 - Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis Phase 3
Completed NCT03521700 - Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement Phase 2/Phase 3
Terminated NCT00180544 - Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease Phase 3
Recruiting NCT02770066 - A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
Terminated NCT01755858 - Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery Phase 1/Phase 2
Completed NCT00027469 - MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery Phase 1
Completed NCT00490841 - The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis N/A
Recruiting NCT03530748 - On-table Renal Perfusion Evaluation Renal Artery Stenosis or Obstruction
Completed NCT00081731 - Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions Phase 3